EP1052977A4 - TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES OF GASTROINTESTINAL TACTRA - Google Patents

TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES OF GASTROINTESTINAL TACTRA

Info

Publication number
EP1052977A4
EP1052977A4 EP98907382A EP98907382A EP1052977A4 EP 1052977 A4 EP1052977 A4 EP 1052977A4 EP 98907382 A EP98907382 A EP 98907382A EP 98907382 A EP98907382 A EP 98907382A EP 1052977 A4 EP1052977 A4 EP 1052977A4
Authority
EP
European Patent Office
Prior art keywords
treatment
gastrointestinal tract
chronic inflammatory
inflammatory disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98907382A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1052977A1 (en
Inventor
Joel Bolonick
Alan Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1052977A1 publication Critical patent/EP1052977A1/en
Publication of EP1052977A4 publication Critical patent/EP1052977A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP98907382A 1998-02-09 1998-02-09 TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES OF GASTROINTESTINAL TACTRA Withdrawn EP1052977A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002265 WO1999039699A1 (en) 1998-02-09 1998-02-09 Treatment of chronic inflammatory disorders of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
EP1052977A1 EP1052977A1 (en) 2000-11-22
EP1052977A4 true EP1052977A4 (en) 2006-07-12

Family

ID=22266344

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98907382A Withdrawn EP1052977A4 (en) 1998-02-09 1998-02-09 TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES OF GASTROINTESTINAL TACTRA

Country Status (9)

Country Link
EP (1) EP1052977A4 (enExample)
JP (1) JP2002502812A (enExample)
KR (1) KR20010040646A (enExample)
CN (1) CN1149078C (enExample)
AU (1) AU735084B2 (enExample)
CA (1) CA2320087C (enExample)
IL (1) IL137598A (enExample)
SE (1) SE0002831L (enExample)
WO (1) WO1999039699A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
MD2852C2 (ro) * 2005-03-28 2006-04-30 Георге АНГЕЛИЧ Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
ES2423929T3 (es) * 2007-02-16 2013-09-25 Aska Pharmaceutical Co., Ltd. Composición farmacéutica que contiene suspensión basada en aceite de partículas finas
LT3354276T (lt) 2007-11-13 2020-04-27 Meritage Pharma, Inc. Kompozicijos, skirtos skrandžio ir žarnyno uždegimo gydymui
US9050368B2 (en) 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024893A1 (en) * 1994-03-16 1995-09-21 R.P. Scherer Limited Delivery systems for hydrophobic drugs
WO1995031217A1 (en) * 1994-05-16 1995-11-23 Dumex-Alpharma A/S Tocopherol compositions for delivery of biologically active agents
WO1995035100A1 (en) * 1994-06-21 1995-12-28 Danbiosyst Uk Limited Colonic drug delivery composition
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
EP0888778A1 (en) * 1997-07-03 1999-01-07 Samyang Corporation Colon selective drug delivery system and compositions comprising said system
EP0919228A1 (en) * 1996-08-02 1999-06-02 Hisamitsu Pharmaceutical Co., Inc. Capsules for oral preparations and capsule preparations for oral administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
WO1995024893A1 (en) * 1994-03-16 1995-09-21 R.P. Scherer Limited Delivery systems for hydrophobic drugs
WO1995031217A1 (en) * 1994-05-16 1995-11-23 Dumex-Alpharma A/S Tocopherol compositions for delivery of biologically active agents
WO1995035100A1 (en) * 1994-06-21 1995-12-28 Danbiosyst Uk Limited Colonic drug delivery composition
EP0919228A1 (en) * 1996-08-02 1999-06-02 Hisamitsu Pharmaceutical Co., Inc. Capsules for oral preparations and capsule preparations for oral administration
EP0888778A1 (en) * 1997-07-03 1999-01-07 Samyang Corporation Colon selective drug delivery system and compositions comprising said system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9939699A1 *

Also Published As

Publication number Publication date
IL137598A (en) 2005-09-25
CA2320087A1 (en) 1999-08-12
AU6320098A (en) 1999-08-23
CN1284869A (zh) 2001-02-21
SE0002831L (sv) 2000-09-28
KR20010040646A (ko) 2001-05-15
CA2320087C (en) 2006-12-19
EP1052977A1 (en) 2000-11-22
CN1149078C (zh) 2004-05-12
JP2002502812A (ja) 2002-01-29
SE0002831D0 (sv) 2000-08-07
WO1999039699A1 (en) 1999-08-12
AU735084B2 (en) 2001-06-28
IL137598A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ZA200401004B (en) Combination for the treatment of inflammatory disorders
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
GB9723553D0 (en) Prediction of the risk of chronic obstructive airway disease
EP1578385A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY INTESTINAL DISEASES
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
IL153425A0 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
GB0123156D0 (en) Treatment of chronic joint inflammation
AU2555397A (en) Macrophage stimulating protein for the treatment of gastrointestinal disorders
IL137598A0 (en) Treatment of chronic inflammatory disorders of the gastrointestinal tract
IL143636A0 (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
GB9825904D0 (en) Diagnosis of gastric and lung disorders
IL153320A0 (en) Phytonutrient formula for the relief of chronic pain resulting from inflammation
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
PL351554A1 (en) Osanetant in the treatment of mood disorders
IL154378A0 (en) Compounds for the treatment of addictive disorders
AUPP687298A0 (en) Herbal compositions for treatment of gastrointestinal disorders
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU3582101A (en) The treatment of functional gastrointestinal disorders
GB9816349D0 (en) The treatment of inflammatory disorders
GB9816352D0 (en) The treatment of inflammatory disorders
GB0004998D0 (en) The treatment of functional gastrointestinal disorders
PL368586A1 (en) Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
GB9416865D0 (en) Treatment of inflammatory diseases of the gastro-intestinal tract

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000814

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20060613

17Q First examination report despatched

Effective date: 20070410

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/48 20060101AFI20140904BHEP

Ipc: A61K 31/58 20060101ALI20140904BHEP

Ipc: A61K 47/44 20060101ALI20140904BHEP

INTG Intention to grant announced

Effective date: 20140918

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150129